This suggested that PYGB might play a central role in shaping the tumor immune infiltration microenvironment in lung cancer, potentially highlighting its role as a therapeutic target for immunomodulatory strategies, and that further studies were needed to clarify the relationship. The gene discussed is PYGB; the disease is lung cancer.